Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_assertion type Assertion NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_head.
- NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_assertion description "[We measured plasma sHLA-G levels in 166 patients with early stages of colorectal cancer (CRC, n = 37), gastric cancer (GC, n = 28), esophageal squamous cell carcinoma (ESCC, n = 58) and non-small cell lung cancer (NSCLC, n = 43), and compared them to healthy controls (n = 260) by using a specific HLA-G enzyme-linked immunosorbent assay (ELISA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_provenance.
- NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_assertion evidence source_evidence_literature NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_provenance.
- NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_assertion SIO_000772 21726203 NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_provenance.
- NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_assertion wasDerivedFrom befree-20140225 NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_provenance.
- NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_assertion wasGeneratedBy ECO_0000203 NP647373.RA1fghfzUGwoW98BpXWu7uYSSZ_L9lilVBPYgORT1y4tA130_provenance.